WHO consolidated guidelines on tuberculosis rapid diagnostics for tuberculosis detection
Autor principal: | |
---|---|
Autor Corporativo: | |
Formato: | Libro electrónico |
Idioma: | Inglés |
Publicado: |
Geneva :
World Health Organization
[2021]
|
Edición: | 2021 update |
Materias: | |
Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009632232806719 |
Tabla de Contenidos:
- Intro
- Contents
- Acknowledgements
- Molecular assays intended as initial tests
- Guideline Development Group
- External Review Group
- Systematic review team
- Consultants with additional technical expertise
- Observers
- WHO steering committee
- Funding
- Loop-mediated isothermal amplification
- WHO Steering Group
- Members of the WHO GDG
- Systematic review authors
- External Review Group
- Acknowledgement of financial support
- First-line line probe assay
- WHO Steering Group
- Members of the WHO GDG
- Systematic review authors
- Observers
- External Review Group
- Acknowledgement of financial support
- Second-line line probe assay
- Abbreviations and acronyms
- Definitions
- Executive summary
- 1. Introduction
- 1.1. Background
- 1.2. Scope of the document
- 1.3. Target audience
- 2. Recommendations
- 2.1. Initial diagnostic tests for diagnosis of TB with drug-resistance detection
- Research priorities
- Implementation considerations
- Findings of the review and interviews
- User perspective
- Cost-effectiveness analysis
- Justification and evidence
- Test description
- Recommendation
- High complexity reverse hybridization-based NAATs for detection of pyrazinamide resistance
- Research priorities
- Implementation considerations
- Performance of SL-LPA on sputum specimens and culture isolates
- Justification and evidence
- Test description
- Recommendations
- Second-line LPAs
- Research priorities
- Implementation considerations
- References
- Annex 1: Guideline development methods
- Methods used to develop World Health Organization guidelines
- Formulation of the recommendations
- Priority of a problem
- Test accuracy
- Balance between desirable and undesirable effects
- Certainty of the evidence
- Certainty of management.
- Confidence in values and preferences and their variability
- Resource requirements
- Cost-effectiveness
- Equity
- Acceptability
- Feasibility
- Annex 2: Conflict of interest assessment for Guideline Development Group and External Review Group members.